Advanced SearchNewsfeedFollowed Companies

Dr.Reddy's's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Dr.Reddy's is a pharmaceutical company that develops drugs for cardiovascular and oncology treatments.

Dr.Reddy's is a Pu... Read more

Annual Revenue

Employees

Erez Israeli's photo - CEO of Dr.Reddy's

CEO

Erez Israeli

CEO Approval Rating

70/100

OVERVIEW

Founded:

1984

Headquarters:

HyderabadAndhra Pradesh

Status:

PublicNYSERDY

Industry Sector:

Health Care Services

SIC Code:

8000NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Aurobindo Pharma a competitor of Dr.Reddy's?

I don't know

Trending News for Dr.Reddy's and Dr.Reddy's's Competitors

February 24, 2020

Medical Buyer

USFDA Reverses Status Of Aurobindo Pharma Ltd's General Injectable Formulation Unit

Aurobindo Pharma Ltd has announced in reference to the USFDA inspection of Unit IV, a general injecta... See more »

February 21, 2020

Medical Buyer

Cipla Ltd Board To Consider Interim Dividend For FY2020

A meeting of the Board of Directors of the Company is scheduled on 12/03/2020, to consider and approv... See more »

February 21, 2020

Medical Buyer

Dr. Reddy's Laboratories Ltd Receives EIR For Duvvada Formulations Plant

Dr. Reddy's Laboratories Ltd. has announced regarding the audit of its Formulations Manufacturing Pla... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Sun Pharma is Dr.Reddy's's #1 rival. Sun Pharma is a Public company that was founded in Mumbai, Maharashtra in 1983. Sun Pharma competes in the Pharmaceuticals field. Sun Pharma has 9,825 more employees vs. Dr.Reddy's.

Lupin is perceived as one of Dr.Reddy's's biggest rivals. Lupin was founded in 1968, and is headquartered in Mumbai, Maharashtra. Lupin is in the Pharmaceuticals field. Lupin generates $221.8M less revenue vs. Dr.Reddy's.

Cipla is a top competitor of Dr.Reddy's. Cipla is a Public company that was founded in 1935 in Mumbai, Maharashtra. Cipla competes in the Pharmaceuticals industry. Compared to Dr.Reddy's, Cipla has 9,940 fewer employees.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Erez Israeli

CEO

- -
22,175
$0
$2.4B
1

Dilip S. Shanghvi

Managing Director

67/100
32,000
- -
$4.8B
2

Vinita Gupta

CEO

74/100
17,042
- -
$2.2B
3

Umang Vohra

CEO

65/100
12,235
- -
$1.9B
4

Govindarajan Narayanan

Managing Director

68/100
22,000
- -
$2.7B
5

Glenn Saldanha

Managing Director

71/100
14,027
- -
$1.6B
6

K.V. Subramaniam

President & CEO

72/100
125
- -
$10M
7

Syed Kazmi

President & CEO

60/100
2,390
- -
$1.1B
8

Sharvil P. Patel

Managing Director

74/100
12,227
- -
$1.8B
9

Sanjay Bhatia

Managing Director

92/100
5,000
- -
$130M
10

Binish Chudgar

Managing Director

70/100
2,000
$107M
$120M
The top 10 competitors in Dr.Reddy's' competitive set are Sun Pharma, Lupin, Cipla, Aurobindo Pharma, Glenmark, Reliance Life Sciences, Jubilant Life Sciences, Zydus Cadila, Laborate and Intas. Together they have raised over 107.0M between their estimated 119.0K employees. Dr.Reddy's has 22,175 employees and is ranked 2nd among it's top 10 competitors. The top 10 competitors average 12,838.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$2.4B

Dr.Reddy's's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 1.7B. Over the last three quarters, Dr.Reddy's's revenue has grown by 12.7%. Specifically, in Q3 2019's revenue was $681.8M; in Q2 2019, it was $558.4M; in Q1 2019, it was $605M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

-

Mar 2017

Source »
$306.6K
-

These are all the companies that Dr.Reddy's has acquired. Dr.Reddy's' latest acquisition was in Mar 2017.

Investments

No recent investments found related to Dr.Reddy's

Dr.Reddy's News

February 17, 2020in-PharmaTechnologist

Dr Reddy's picks up portfolio and facility from rival for $259m

Wockhardt sells part of its domestic business to fund growth in international markets and to develop ... See more »
February 17, 2020Medical Buyer

DRL To Initiate Voluntary Action At Duvvada Unit

Hyderabad: City-based pharma behemoth Dr Reddy's Laboratories on Sunday informed the bourses that the... See more »
February 14, 2020moneycontrol

Will the Wockhardt move help Dr Reddy#39;s break into the big league?

Analysts say unlike previous attempts, Dr Reddy’s is making more concerted effort to expand in Indi... See more »
February 13, 2020Pharamceutical Technology

Dr Reddy's to buy some Wockhardt generics units for $259m

Dr Reddy's Laboratories has signed a definitive agreement to acquire certain divisions of Wockhardt's... See more »
February 13, 2020The Financial Express

Dr. Reddy's Laboratories share price hits 52-week high after finalising deal with Wockhardt

A day after entering into a definitive agreement with Wockhardt Limited to acquire select divisions o... See more »
February 13, 2020Business Standard

Wockhardt tanks 5% after it sells domestic branded ops to Dr Reddy's Labs

The deal, which could fetch a consideration amount of Rs 1,850 crore, is expected to close in the fir... See more »
February 12, 2020Equity Bulls

Wockhardt to raise INR 1,850 crore by sale of part of portfolio of its Domestic Branded Business

Wockhardt to raise INR 1,850 crore by sale of part of portfolio of its Domestic Branded Business...... See more »

Dr.Reddy's Press Releases

January 11, 2019StreetInsider

Dr. Reddy's to Release Q3 FY19 Results on February 1, 2019

HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) w... See more »
December 24, 2018streetinsider

Dr. Reddy's Laboratories Launches Aspirin and Extended-Release Dipyridamole Capsules in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE:... See more »
April 10, 2018StreetInsider

Mezzion Wins Appellate Jurisdiction Fight Against Dr. Reddy's

SEOUL, South Korea, April 9, 2018 /PRNewswire/ -- On March 26, 2018, a New Jersey State Appellate cou... See more »
October 16, 2017StreetInsider

Dr. Reddy's to Release Q2 FY18 Results on October 31, 2017

Dr. Reddy's Laboratories (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) will announce results for the Secon... See more »
July 13, 2017StreetInsider

Dr. Reddy's to Release Q1 FY18 Results on July 27, 2017

Dr. Reddy's Laboratories (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) will announce results for the First... See more »
December 21, 2016Blackbird

Siddarth Bhamre

Never miss a great news story!Get instant notifications from Economic TimesAllowNot now You can switc... See more »
December 9, 2016openPR

Global MAb Biosimilars Market to grow at a CAGR of 4-7% during 2016-2020

About Biosimilars Biosimilars or follow-on biologics are generic versions of the biopharmaceutical pr... See more »

Dr.Reddy's Videos

February 26, 2019Dr.Reddy's Vimeo Channel

"QCM Q3 FY19 G V Prasad" on VIMEO

Cast: Dr. Reddy's Laboratories Ltd.... See more »
January 30, 2019Dr.Reddy's Vimeo Channel

"Good Health Can't Wait" on VIMEO

We at Dr.Reddy's believe that medical care and attention is everyone's right. We place our patients i... See more »
July 30, 2018Dr.Reddy's Vimeo Channel

"K Satish Reddy" on VIMEO

Cast: Dr. Reddy's Laboratories Ltd.... See more »
June 20, 2018Dr.Reddy's Vimeo Channel

"ET Now First Trades 18 June 2018 12min 13sec Mr. Saumen Chakraborty - Dr Reddy's 09.42am" on VIMEO

Cast: Dr. Reddy's Laboratories Ltd.... See more »
January 3, 2018Dr.Reddy's Vimeo Channel

"Inject Fondaparinux Sodium French Canadian_Subtitled (1)" on VIMEO

Cast: Dr. Reddy's Laboratories Ltd.... See more »
December 28, 2017Dr.Reddy's Vimeo Channel

"Inject Fondaparinux Sodium French Canadian" on VIMEO

Cast: Dr. Reddy's Laboratories Ltd.... See more »
December 28, 2017Dr.Reddy's Vimeo Channel

"Inject Fondaparinux Sodium_Subtitled" on VIMEO

Cast: Dr. Reddy's Laboratories Ltd.... See more »

Social Statistics

Headquarters

8-2-337, Road No. 3 Banjara Hills

Hyderabad, Andhra Pradesh500 034

91-40-49002900

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Dr.Reddy's is a pharmaceutical company that develops drugs for cardiovascular and oncology treatments. Dr.Reddy's was founded in 1984. Dr.Reddy's' headquarters is located in Hyderabad, Andhra Pradesh, IN 500 034. Dr.Reddy's' latest acquisition was . D...

CEO

Dr.Reddy's's CEO, Erez Israeli, currently has an approval rating of 70%. Dr.Reddy's's primary competitors are Sun Pharma, Lupin & Cipla.

Website

drreddys.com

Frequently Asked Questions about Dr.Reddy's

  1. When was Dr.Reddy's founded?

    Dr.Reddy's was founded in 1984

  2. Who is Dr.Reddy's's CEO?

    Dr.Reddy's's CEO is Erez Israeli

  3. How much revenue does Dr.Reddy's generate?

    Dr.Reddy's generates $2.4B in revenue

  4. How much funding does Dr.Reddy's have?

    Dr.Reddy's has historically raised $0 in funding

  1. Where is Dr.Reddy's's headquarters?

    Dr.Reddy's's headquarters is in Hyderabad Andhra Pradesh, IN

  2. How many employees does Dr.Reddy's have?

    Dr.Reddy's has 22,175 employees

  3. What sector does Dr.Reddy's operate in?

    Dr.Reddy's is in Health Care Services

  4. Who are Dr.Reddy's's competitors?

    Dr.Reddy's's top competitors are Sun Pharma, Lupin, Cipla
Stay up-to-date with the latest news on Dr.Reddy's